Pam Stetkiewicz

Supporter
DISC Type : s

Member Board of Directors at Genezen

Cambridge, Massachusetts, United States

Overview

Pam Stetkiewicz is the Chief Operating Officer at Arbor Biotechnologies, a biotech executive with over 20 years of experience in drug development. She specializes in small molecules, biotherapeutics, and gene therapy, holding a PhD from The Johns Hopkins University. She is also a board member at Genezen and ImmuneID.

Outside of work, Pam enjoys spending time with her husband and two sons, relaxing at the beach, and is an avid golfer. She is passionate about building strong company cultures and is inspired by the resiliency of the rare disease community.

A key highlight of her career was leading the team that filed the first-ever IND for an in vivo CRISPR therapeutic while at Editas Medicine.

Personality Overview

Thoughtful In Approach

Social Proof Driven

Procedural

They are unlikely to become strong champions as they don't prefer pushing other people.  They are good and approachable with everyone, internally and externally. They usually go by the book, following all rules and procedures.

Topics They Care About

Gene Therapy
As COO of Arbor Bio, a genetic medicines company, and a board member at Genezen, a viral vector producer, she is deeply involved in advancing gene therapies.
Rare Disease Advocacy
Actively supports the rare disease community, stating her team is inspired by their resiliency and committed to advancing treatments for conditions like primary hyperoxaluria.
Company Culture
Champions a healthy company culture, viewing it as a core part of building a successful organization and often posts about combining great science with a great culture.

Media Appearances

Genezen Welcomes Industry Experts Dr. Pam Stetkiewicz and Stuart Auerbach to Board of Directors. Featured in PR Newswire

See Now

Work History

11-2024
Member Board of Directors at Genezen
7-2021
Chief Operating Officer at Arbor Biotechnologies
7-2022 - 10-2023
Member Board Of Directors, designee of ARCH Venture Partners at ImmuneID
4-2020 - 6-2021
Senior Vice President, Global Program Leader at Flagship Pioneering
2-2016 - 3-2020
Vice President Program and Alliance Management at Editas Medicine

Education

1993 - 1999
PhD from The Johns Hopkins University

More Information

Social Presence :

Prographics :

Exp : 8 Location : Cambridge, Massachusetts, United States Job Level : Leadership Designation : Member Board of Directors at Genezen
URL has been copied!

Insights For Selling To Pam

During A Call Or A Meeting

DO's

  • Engage other key stakeholders on their side and leverage if they approve of your product
  • Focus your pitch on the impact that you could help them have on their organization
  • Talk about refund and cancellation policy if the need arises

DONT's

  • Avoid saying anything that sounds like a risky proposition
  • Don’t keep pushing them for a straight answer, just make your own conclusions
  • Don’t use phrases like ‘there might be’, ‘we haven’t yet’, ‘latest technology’ etc.

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Pam is

  • Low risk, approval of other stakeholders and successful process-based evaluation are most important for them.
  • Will you ever get a clear answer from Pam

  • They don’t say no very often, and can take you around in circles sometimes.

Insights For Deal Planning

    How fast (or slow) will Pam move?

  • They do not like to rush, so they could be slow in making decisions.
  • Can Pam take some risk or not?

  • They are risk-averse and like to make decisions that others support.

You And Pam

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.